These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 22389456)

  • 1. Diabetic murine models for Acinetobacter baumannii infection.
    Luo G; Spellberg B; Gebremariam T; Bolaris M; Lee H; Fu Y; French SW; Ibrahim AS
    J Antimicrob Chemother; 2012 Jun; 67(6):1439-45. PubMed ID: 22389456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of tigecycline/colistin combination in a pneumonia model caused by extensively drug-resistant Acinetobacter baumannii.
    Mutlu Yilmaz E; Sunbul M; Aksoy A; Yilmaz H; Guney AK; Guvenc T
    Int J Antimicrob Agents; 2012 Oct; 40(4):332-6. PubMed ID: 22831842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
    Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
    Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratracheal colistin sulfate for BALB/c mice with early pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Chiang SR; Chuang YC; Tang HJ; Chen CC; Chen CH; Lee NY; Chou CH; Ko WC
    Crit Care Med; 2009 Sep; 37(9):2590-5. PubMed ID: 19623044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological characterization of carbapenem-resistant Acinetobacter baumannii bloodstream infections.
    Song JY; Cheong HJ; Choi WS; Heo JY; Noh JY; Kim WJ
    J Med Microbiol; 2011 May; 60(Pt 5):605-611. PubMed ID: 21233298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pharmacokinetic/pharmacodynamic studies of systemically administered colistin against Pseudomonas aeruginosa and Acinetobacter baumannii in mouse thigh and lung infection models: smaller response in lung infection.
    Cheah SE; Wang J; Nguyen VT; Turnidge JD; Li J; Nation RL
    J Antimicrob Chemother; 2015 Dec; 70(12):3291-7. PubMed ID: 26318190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii bacteremia: Impact on empiric therapy and antibiotic resistance.
    Teng SO; Yen MY; Ou TY; Chen FL; Yu FL; Lee WS
    J Microbiol Immunol Infect; 2015 Oct; 48(5):525-30. PubMed ID: 25103719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of mortality in patients with extensively drug-resistant Acinetobacter baumannii pneumonia receiving colistin therapy.
    Choi IS; Lee YJ; Wi YM; Kwan BS; Jung KH; Hong WP; Kim JM
    Int J Antimicrob Agents; 2016 Aug; 48(2):175-80. PubMed ID: 27423416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative evaluation of intratracheal colistimethate sodium, imipenem, and meropenem in BALB/c mice with carbapenem-resistant Acinetobacter baumannii pneumonia.
    Tang HJ; Chuang YC; Ko WC; Chen CC; Shieh JM; Chen CH; Lee NY; Chiang SR
    Int J Infect Dis; 2012 Jan; 16(1):e34-40. PubMed ID: 22088863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Epidemiology and Drug Resistance of Acinetobacter baumannii Isolated from Hospitals in Southern Poland: ICU as a Risk Factor for XDR Strains.
    Chmielarczyk A; Pilarczyk-Żurek M; Kamińska W; Pobiega M; Romaniszyn D; Ziółkowski G; Wójkowska-Mach J; Bulanda M
    Microb Drug Resist; 2016 Jun; 22(4):328-35. PubMed ID: 26745326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humanized Exposures of a β-Lactam-β-Lactamase Inhibitor, Tazobactam, versus Non-β-Lactam-β-Lactamase Inhibitor, Avibactam, with or without Colistin, against Acinetobacter baumannii in Murine Thigh and Lung Infection Models.
    Monogue ML; Sakoulas G; Nizet V; Nicolau DP
    Pharmacology; 2018; 101(5-6):255-261. PubMed ID: 29533955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing Acinetobacter baumannii Virulence and Persistence in a Murine Model of Lung Infection.
    Palmer LD; Green ER; Sheldon JR; Skaar EP
    Methods Mol Biol; 2019; 1946():289-305. PubMed ID: 30798564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis.
    Dinc G; Demiraslan H; Elmali F; Ahmed SS; Metan G; Alp E; Doganay M
    Chemotherapy; 2013; 59(5):325-9. PubMed ID: 24525528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse pneumonia model by Acinetobacter baumannii multidrug resistant strains: Comparison between intranasal inoculation, intratracheal instillation and oropharyngeal aspiration techniques.
    Bergamini G; Perico ME; Di Palma S; Sabatini D; Andreetta F; Defazio R; Felici A; Ferrari L
    PLoS One; 2021; 16(12):e0260627. PubMed ID: 34855837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteremic nosocomial pneumonia caused by Acinetobacter baumannii and Acinetobacter nosocomialis: a single or two distinct clinical entities?
    Lee YT; Kuo SC; Yang SP; Lin YT; Chiang DH; Tseng FC; Chen TL; Fung CP
    Clin Microbiol Infect; 2013 Jul; 19(7):640-5. PubMed ID: 22967204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial efficacy of doripenem and its combinations with sulbactam, amikacin, colistin, tigecycline in experimental sepsis of carbapenem-resistant Acinetobacter baumannii.
    Dinc G; Demiraslan H; Elmali F; Ahmed SS; Alp E; Doganay M
    New Microbiol; 2015 Jan; 38(1):67-73. PubMed ID: 25742149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.
    Dudhani RV; Turnidge JD; Nation RL; Li J
    J Antimicrob Chemother; 2010 Sep; 65(9):1984-90. PubMed ID: 20573659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo bactericidal effect of colistin-linezolid combination in a murine model of MDR and XDR Acinetobacter baumannii pneumonia.
    Ma XL; Guo YZ; Wu YM; Gong WT; Sun J; Huang Z
    Sci Rep; 2020 Oct; 10(1):17518. PubMed ID: 33060737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of rifampin and its combinations with imipenem, sulbactam, and colistin in experimental models of infection caused by imipenem-resistant Acinetobacter baumannii.
    Pachón-Ibáñez ME; Docobo-Pérez F; López-Rojas R; Domínguez-Herrera J; Jiménez-Mejias ME; García-Curiel A; Pichardo C; Jiménez L; Pachón J
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1165-72. PubMed ID: 20047914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.